Recombinant alpha Synuclein Antibody

    应用:
  • IHC
  • WB
功能和特点
  • 宿主种属: 兔(Rabbit)
  • 种属反应性: 人(Human)
  • 亚型: Rabbit IgG
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab088511-10μl
10μl 现货 Stock Image
Ab088511-50μl
50μL 现货 Stock Image
Ab088511-100μl
100μL 期货 Stock Image
Ab088511-1ml
1ml 期货 Stock Image

基本信息

产品名称 Recombinant alpha Synuclein Antibody
别名 Alpha-synuclein抗体 | 核突触蛋白α抗体 | 突触核蛋白α抗体 | 重组 alpha 突触核蛋白抗体
英文别名 Alpha synucleinantibody | Alpha-synuclein antibody | Alpha-synuclein, isoform NACP140antibody | alphaSYN antibody | MGC105443 antibody | MGC110988 antibody | MGC127560 antibody | MGC64356 antibody | NACP antibody | Non A beta component of AD amyloidantibo
规格或纯度 ExactAb™, Validated, 重组, 0.55 mg/mL
宿主种属 兔(Rabbit)
特异性 alpha Synuclein
种属反应性 人(Human)
免疫原 A synthetic peptide derived from human Alpha Synuclein (AA 1-140).
阳性对照 WB: HUVEC, HEK293 and HeLa cell lysates. IHC: Mouse testis tissue.
偶联 Unconjugated

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Rabbit IgG
轻链亚型 kappa
SDS-PAGE 150 kDa
纯化方法 Protein A purified
物理外观 Liquid
储存缓冲液 10mM PBS, 150mM NaCl, 50% Glycerol, 0.05% BSA, 0.02% Sodium azide, pH 7.4
防腐剂 0.02% Sodium azide
浓度 0.55 mg/mL
储存温度 -20°C储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 4°C 短期储存(1-2 周)。-20°C下长期保存(24个月)。收货后建议分装。避免冷冻/解冻循环。
分子类型 抗体

图片

Recombinant alpha Synuclein Antibody (Ab088511) - Western Blot
All lanes: Recombinant alpha Synuclein Antibody (Ab088511) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 14 kDa
Observed band size: 17 kDa
Exposure time: 100.1 s

Recombinant alpha Synuclein Antibody (Ab088511) - Western Blot
All lanes: Recombinant alpha Synuclein Antibody (Ab088511) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 14 kDa
Observed band size: 17 kDa
Exposure time: 7.5 s

Recombinant alpha Synuclein Antibody (Ab088511) - IHC
Immunohistochemistry analysis of paraffin-embedded mouse testis using Recombinant alpha Synuclein Antibody (Ab088511). High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.

关联靶点(人)

SNCA Tchem α-突触核蛋白(Alpha-synuclein) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

安全和危险性(GHS)

质量标准

应用

应用名称 稀释比例
WB

1/500-1/1000

IHC

1/50 - 1/100

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到2个结果

批号(Lot Number) 证书类型 日期 货号
ZJ24F0303216 分析证书 24-03-14 Ab088511
ZJ24F0303217 分析证书 24-03-14 Ab088511

参考文献

1. Tobias S Ulmer,Ad Bax,Nelson B Cole,Robert L Nussbaum.  (2004-12-24)  Structure and dynamics of micelle-bound human alpha-synuclein..  The Journal of biological chemistry,  280  ((10)): (9595-9603).  [PMID:15615727]
2. Kritzer JA, Hamamichi S, McCaffery JM, Santagata S, Naumann TA, Caldwell KA, Caldwell GA, Lindquist S..  (2009)  Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models..  Nat Chem Biol,  (9): (655-663).  [PMID:19597508] [10.1038/nchembio.193]
3. Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P, Lerner RA, Kelly JW..  (2006)  Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization..  Nat Chem Biol,  (5): (249-253).  [PMID:16565714] [10.1038/nchembio782]
4. Yu L, Cui J, Padakanti PK, Engel L, Bagchi DP, Kotzbauer PT, Tu Z..  (2012)  Synthesis and in vitro evaluation of α-synuclein ligands..  Bioorg Med Chem,  20  (15): (4625-4634).  [PMID:22789706] [10.1016/j.bmc.2012.06.023]
5. Sashidhara KV, Modukuri RK, Jadiya P, Rao KB, Sharma T, Haque R, Singh DK, Banerjee D, Siddiqi MI, Nazir A..  (2014)  Discovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson's Disease..  ACS Med Chem Lett,  (10): (1099-1103).  [PMID:25313319] [10.1021/ml500222g]
6. Chu W, Zhou D, Gaba V, Liu J, Li S, Peng X, Xu J, Dhavale D, Bagchi DP, d'Avignon A, Shakerdge NB, Bacskai BJ, Tu Z, Kotzbauer PT, Mach RH..  (2015)  Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils..  J Med Chem,  58  (15): (6002-6017).  [PMID:26177091] [10.1021/acs.jmedchem.5b00571]
7. Ahsan N, Siddique IA, Gupta S, Surolia A..  (2018)  A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity..  Eur J Med Chem,  143  (1174-1184).  [PMID:29150334] [10.1016/j.ejmech.2017.10.002]
8. Liu H, Chen L, Zhou F, Zhang YX, Xu J, Xu M, Bai SP..  (2019)  Anti-oligomerization sheet molecules: Design, synthesis and evaluation of inhibitory activities against α-synuclein aggregation..  Bioorg Med Chem,  27  (14): (3089-3096).  [PMID:31196755] [10.1016/j.bmc.2019.05.032]
9. Liu Y, Jovcevski B, Pukala TL..  (2019)  C-Phycocyanin from Spirulina Inhibits α-Synuclein and Amyloid-β Fibril Formation but Not Amorphous Aggregation..  J Nat Prod,  82  (1): (66-73).  [PMID:30620188] [10.1021/acs.jnatprod.8b00610]
10. Luo D, Sharma H, Yedlapudi D, Antonio T, Reith MEA, Dutta AK..  (2016)  Novel multifunctional dopamine D2/D3 receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation properties..  Bioorg Med Chem,  24  (21): (5088-5102).  [PMID:27591013] [10.1016/j.bmc.2016.08.021]
11. Chen YF, Bian J, Zhang P, Bu LL, Shen Y, Yu WB, Lu XH, Lin X, Ye DY, Wang J, Chu Y..  (2020)  Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system..  Bioorg Med Chem,  28  (7): (115358-115358).  [PMID:32081628] [10.1016/j.bmc.2020.115358]
12. Jennings LK,Prebble DW,Xu M,Ekins MG,Munn AL,Mellick GD,Carroll AR.  (2020)  Anti-prion and α-Synuclein Aggregation Inhibitory Sterols from the Sponge Lamellodysidea cf. chlorea..  J Nat Prod,  83  (12): (3751-3757).  [PMID:33269586] [10.1021/acs.jnatprod.0c01168]
13. Oliveri V.  (2019)  Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation..  Eur J Med Chem,  167  (10-36).  [PMID:30743095] [10.1016/j.ejmech.2019.01.045]
14. Maqbool M,Rajvansh R,Srividya K,Hoda N.  (2020)  Deciphering the robustness of pyrazolo-pyridine carboxylate core structure-based compounds for inhibiting α-synuclein in transgenic C. elegans model of Synucleinopathy..  Bioorg Med Chem,  28  (17): (115640-115640).  [PMID:32773095] [10.1016/j.bmc.2020.115640]
15. Campion, D D and 9 more authors..  (1995)  The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease..  Genomics,  (20): [PMID:7601450]
16. Uéda, K K, Saitoh, T T and Mori, H H..  (1994)  Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid..  Biochemical and biophysical research communications,  (15): [PMID:7802671]
17. Jakes, R R, Spillantini, M G MG and Goedert, M M..  (1994)  Identification of two distinct synucleins from human brain..  FEBS letters,  (23): [PMID:8194594]
18. Uéda, K K and 9 more authors..  (1993)  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease..  Proceedings of the National Academy of Sciences of the United States of America,  (1): [PMID:8248242]
19. Polymeropoulos, M H MH and 19 more authors..  (1997)  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease..  Science (New York, N.Y.),  (27): [PMID:9197268]
20. Krüger, R R and 9 more authors..  (1998)  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease..  Nature genetics,  [PMID:9462735]
21. Okochi, M M and 8 more authors..  (2000)  Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein..  The Journal of biological chemistry,  (7): [PMID:10617630]
22. Pronin, A N AN, Morris, A J AJ, Surguchov, A A and Benovic, J L JL..  (2000)  Synucleins are a novel class of substrates for G protein-coupled receptor kinases..  The Journal of biological chemistry,  (25): [PMID:10852916]
23. Touchman, J W JW and 7 more authors..  (2001)  Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element..  Genome research,  [PMID:11156617]
24. Nakamura, T T, Yamashita, H H, Takahashi, T T and Nakamura, S S..  (2001)  Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125..  Biochemical and biophysical research communications,  (2): [PMID:11162638]
25. Fujiwara, Hideo H and 8 more authors..  (2002)  alpha-Synuclein is phosphorylated in synucleinopathy lesions..  Nature cell biology,  [PMID:11813001]
26. Ahn, Bong-Hyun BH and 15 more authors..  (2002)  alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells..  The Journal of biological chemistry,  (5): [PMID:11821392]
27. and Alves da Costa, C C..  (2003)  Recent advances on alpha-synuclein cell biology: functions and dysfunctions..  Current molecular medicine,  [PMID:12558071]
28. Goers, John J and 7 more authors..  (2003)  Nuclear localization of alpha-synuclein and its interaction with histones..  Biochemistry,  (22): [PMID:12859192]
29. Murray, Ian V J IV and 7 more authors..  (2003)  Role of alpha-synuclein carboxy-terminus on fibril formation in vitro..  Biochemistry,  (22): [PMID:12859200]
30. Takahashi, Tetsuya T and 8 more authors..  (2003)  Identification and characterization of a novel Pyk2/related adhesion focal tyrosine kinase-associated protein that inhibits alpha-synuclein phosphorylation..  The Journal of biological chemistry,  (24): [PMID:12893833]
31. Zarranz, Juan J JJ and 14 more authors..  (2004)  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia..  Annals of neurology,  [PMID:14755719]
32. Dalfó, E E, Barrachina, M M, Rosa, J L JL, Ambrosio, S S and Ferrer, I I..  (2004)  Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease..  Neurobiology of disease,  [PMID:15207266]
33. Fortin, Doris L DL and 5 more authors..  (2004)  Lipid rafts mediate the synaptic localization of alpha-synuclein..  The Journal of neuroscience : the official journal of the Society for Neuroscience,  (28): [PMID:15282274]
34. Choi, Woong W and 6 more authors..  (2004)  Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein..  FEBS letters,  (22): [PMID:15498564]
35. Ahn, Jung Sun JS, Lee, Jung-Ho JH, Kim, Je-Hoon JH and Paik, Seung R SR..  (2007)  Novel method for quantitative determination of amyloid fibrils of alpha-synuclein and amyloid beta/A4 protein by using resveratrol..  Analytical biochemistry,  (15): [PMID:17597573]
36. Waxman, Elisa A EA, Mazzulli, Joseph R JR and Giasson, Benoit I BI..  (2009)  Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization..  Biochemistry,  (13): [PMID:19722699]
37. Xie, Yuan-Yuan YY and 8 more authors..  (2010)  Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology,  [PMID:19762560]
38. Burré, Jacqueline J and 5 more authors..  (2010)  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro..  Science (New York, N.Y.),  (24): [PMID:20798282]
39. Dudzik, Christopher G CG, Walter, Eric D ED and Millhauser, Glenn L GL..  (2011)  Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease..  Biochemistry,  (22): [PMID:21319811]
40. Zhao, Minglei M, Cascio, Duilio D, Sawaya, Michael R MR and Eisenberg, David D..  (2011)  Structures of segments of α-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formation..  Protein science : a publication of the Protein Society,  [PMID:21462277]
41. Bartels, Tim T, Choi, Joanna G JG and Selkoe, Dennis J DJ..  (2011)  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation..  Nature,  (14): [PMID:21841800]
42. Rose, Frisco; Hodak, Miroslav and Bernholc, Jerzy..  (2011)  Mechanism of copper(II)-induced misfolding of Parkinson's disease protein..  Scientific reports,  [PMID:22355530]
43. Trexler, Adam J AJ and Rhoades, Elizabeth E..  (2012)  N-Terminal acetylation is critical for forming α-helical oligomer of α-synuclein..  Protein science : a publication of the Protein Society,  [PMID:22407793]
44. Falsone, S Fabio SF and 17 more authors..  (2012)  SERF protein is a direct modifier of amyloid fiber assembly..  Cell reports,  (30): [PMID:22854022]
45. Proukakis, Christos C and 7 more authors..  (2013)  A novel α-synuclein missense mutation in Parkinson disease..  Neurology,  (12): [PMID:23427326]
46. Appel-Cresswell, Silke S and 14 more authors..  (2013)  Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society,  [PMID:23457019]
47. Gruschus, James M; Yap, Thai Leong; Pistolesi, Sara; Maltsev, Alexander S and Lee, Jennifer C..  (2013)  NMR structure of calmodulin complexed to an N-terminally acetylated α-synuclein peptide..  Biochemistry,  (21): [PMID:23607618]
48. Khalaf, Ossama O and 11 more authors..  (2014)  The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity..  The Journal of biological chemistry,  (8): [PMID:24936070]
49. Tsigelny, Igor F IF and 10 more authors..  (2015)  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions..  ACS chemical neuroscience,  (18): [PMID:25561023]
50. Rodriguez, Jose A JA and 20 more authors..  (2015)  Structure of the toxic core of α-synuclein from invisible crystals..  Nature,  (24): [PMID:26352473]
51. Butler, Brittany B and 7 more authors..  (2015)  Dopamine Transporter Activity Is Modulated by α-Synuclein..  The Journal of biological chemistry,  (4): [PMID:26442590]
52. Tuttle, Marcus D MD and 15 more authors..  (2016)  Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein..  Nature structural & molecular biology,  [PMID:27018801]
53. Chai, Ye Jin YJ and 11 more authors..  (2016)  Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation..  The Journal of cell biology,  (12): [PMID:27597756]
54. Logan, Todd T, Bendor, Jacob J, Toupin, Chantal C, Thorn, Kurt K and Edwards, Robert H RH..  (2017)  α-Synuclein promotes dilation of the exocytotic fusion pore..  Nature neuroscience,  [PMID:28288128]
55. Li, Binsen B and 12 more authors..  (2018)  Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel..  Nature communications,  (6): [PMID:30190461]
56. Huang, Chien-Chang CC and 5 more authors..  (2018)  Soluble α-synuclein facilitates priming and fusion by releasing Ca2+ from the thapsigargin-sensitive Ca2+ pool in PC12 cells..  Journal of cell science,  (29): [PMID:30404828]
57. Merle, David A DA and 12 more authors..  (2019)  Increased Aggregation Tendency of Alpha-Synuclein in a Fully Disordered Protein Complex..  Journal of molecular biology,  (28): [PMID:31034892]
58. Thomas R Burkard,Melanie Planyavsky,Ines Kaupe,Florian P Breitwieser,Tilmann Bürckstümmer,Keiryn L Bennett,Giulio Superti-Furga,Jacques Colinge.  (2011-01-29)  Initial characterization of the human central proteome..  BMC systems biology,  (17-17).  [PMID:21269460]

溶液计算器